ATE401406T1 - Hühner-anaemie-virus mutante, impfstoffe, und verwendungen basiert auf virusprotein vp3, oder dafür kodierende virus-sequenzen - Google Patents

Hühner-anaemie-virus mutante, impfstoffe, und verwendungen basiert auf virusprotein vp3, oder dafür kodierende virus-sequenzen

Info

Publication number
ATE401406T1
ATE401406T1 AT01205103T AT01205103T ATE401406T1 AT E401406 T1 ATE401406 T1 AT E401406T1 AT 01205103 T AT01205103 T AT 01205103T AT 01205103 T AT01205103 T AT 01205103T AT E401406 T1 ATE401406 T1 AT E401406T1
Authority
AT
Austria
Prior art keywords
cav
virus
vaccines
protein
induction
Prior art date
Application number
AT01205103T
Other languages
English (en)
Inventor
Mathieu Hubertus Mari Noteborn
Guus Koch
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leadd Bv filed Critical Leadd Bv
Application granted granted Critical
Publication of ATE401406T1 publication Critical patent/ATE401406T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01205103T 1993-07-20 1994-07-19 Hühner-anaemie-virus mutante, impfstoffe, und verwendungen basiert auf virusprotein vp3, oder dafür kodierende virus-sequenzen ATE401406T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9301272A NL9301272A (nl) 1993-07-20 1993-07-20 Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.

Publications (1)

Publication Number Publication Date
ATE401406T1 true ATE401406T1 (de) 2008-08-15

Family

ID=19862681

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01205103T ATE401406T1 (de) 1993-07-20 1994-07-19 Hühner-anaemie-virus mutante, impfstoffe, und verwendungen basiert auf virusprotein vp3, oder dafür kodierende virus-sequenzen
AT94925638T ATE236980T1 (de) 1993-07-20 1994-07-19 Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94925638T ATE236980T1 (de) 1993-07-20 1994-07-19 Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen

Country Status (13)

Country Link
US (1) US5952002A (de)
EP (2) EP1253201B1 (de)
JP (1) JP3829290B2 (de)
AT (2) ATE401406T1 (de)
AU (1) AU703187B2 (de)
CA (1) CA2167578C (de)
DE (2) DE69435117D1 (de)
DK (2) DK1253201T3 (de)
ES (2) ES2311005T3 (de)
NL (1) NL9301272A (de)
PT (2) PT1253201E (de)
WO (1) WO1995003414A2 (de)
ZA (1) ZA945275B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
US6162461A (en) * 1990-09-12 2000-12-19 Leadd B.V. Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
EP0872552A1 (de) * 1997-04-15 1998-10-21 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 induzierendes Protein und/oder Apoptin exprimiert
EP0878546A1 (de) * 1997-04-15 1998-11-18 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
WO1996041191A1 (en) * 1995-06-07 1996-12-19 Aesculaap B.V. Methods and uses for apoptin
WO1996040931A1 (en) * 1995-06-07 1996-12-19 Aesculaap B.V. Neutralizing conformational epitopes of chicken anemia virus
EP0927757A1 (de) * 1997-12-03 1999-07-07 Leadd B.V. Verfahren und Mitteln um Apoptose zu induzieren durch Interferenz mit Bip-ähnliche Proteine
US7361730B1 (en) * 1999-03-15 2008-04-22 University Of Maryland Surface localized colligin/Hsp47 in carcinoma cells
EP1199363A1 (de) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylationsmodifikationen von Apoptin
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines
US20080226669A1 (en) 2005-12-29 2008-09-18 Boehringer Ingelheim Vetmedica, Inc. Multivalent pcv2 immunogenic compositions and methods of producing such compositions
PL2371383T3 (pl) 2005-12-29 2016-01-29 Boehringer Ingelheim Vetmedica Inc Zastosowanie kompozycji immunogennej do zmniejszania objawów klinicznych u świń
CN102311928B (zh) * 2011-08-25 2013-04-24 中国农业科学院哈尔滨兽医研究所 鸡贫血病毒vp1、vp2蛋白共表达的重组酵母工程菌、其构建方法及应用
CN108431024A (zh) 2015-10-16 2018-08-21 堪萨斯州立大学研究基金会 猪3型圆环病毒免疫原性组合物以及其制备和使用方法
JP7053488B2 (ja) * 2016-04-26 2022-04-12 ロンドン スクール オブ ハイジーン アンド トロピカル メディシン レオウイルス科ワクチン
CN113980146B (zh) * 2021-11-11 2022-09-27 扬州优邦生物药品有限公司 三聚体化鸭黄病毒E蛋白domainIII、其制备方法和运用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.

Also Published As

Publication number Publication date
JP3829290B2 (ja) 2006-10-04
DK1253201T3 (da) 2008-11-17
EP1253201B1 (de) 2008-07-16
NL9301272A (nl) 1995-02-16
DE69435117D1 (de) 2008-08-28
DE69432486T2 (de) 2004-03-04
EP0784685A2 (de) 1997-07-23
EP1253201A3 (de) 2003-01-08
DE69432486D1 (de) 2003-05-15
EP0784685B1 (de) 2003-04-09
ZA945275B (en) 1995-02-24
EP1253201A2 (de) 2002-10-30
CA2167578A1 (en) 1995-02-02
AU703187B2 (en) 1999-03-18
ES2196032T3 (es) 2003-12-16
US5952002A (en) 1999-09-14
ES2311005T3 (es) 2009-02-01
PT784685E (pt) 2003-08-29
WO1995003414A2 (en) 1995-02-02
PT1253201E (pt) 2008-10-27
ATE236980T1 (de) 2003-04-15
DK0784685T3 (da) 2003-08-04
JPH09504941A (ja) 1997-05-20
WO1995003414A3 (en) 1995-03-02
CA2167578C (en) 2007-03-13
AU7547394A (en) 1995-02-20

Similar Documents

Publication Publication Date Title
ATE401406T1 (de) Hühner-anaemie-virus mutante, impfstoffe, und verwendungen basiert auf virusprotein vp3, oder dafür kodierende virus-sequenzen
DK84194A (da) Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
ATE453403T1 (de) Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert
GR3035458T3 (en) Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
BR9712592A (pt) Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
DE69942925D1 (de) Abgeschwächte Salmonella SP12 Mutante als Antigen-Träger.
EP0837928A4 (de) Zusammensetzungen aus rekombinierten poxvirus-cytomegalovirus und ihre verwendung
DE69737125D1 (de) Streptococcus pneumoniae antigene und impfstoffe
FI102382B1 (fi) Ilmentämisjärjestelmä ihmisen respiratory syncytial -viruksen glykoproteiinien immunogeenisia fragmentteja sisältäviä kimeerisiä glykoproteiineja varten
DK179290D0 (da) Rekombinante cmv-neutraliserende proteiner
DE69434985D1 (de) Immunogene zusammensetzungen gegen eine helicobacterinfektion, verwendung von polypeptiden in diesen zusammensetzungen und nukleinsäurendie besagte polypeptide kodieren
FI861485A0 (fi) Producering av immunologiskt reaktiva virala proteiner.
ATE159170T1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
ZA200400289B (en) Chimeric chains that code for proteins that induce effects directed against viruses.
ATE71534T1 (de) Vakzine.
DE69019092D1 (de) Von Babesia abgeleitete Antigene und Polypeptide (12D3-Antigen).
DK230890A (da) Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m.
IT1276765B1 (it) Gene del cromosoma x umano e proteina codificata da detto gene.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1253201

Country of ref document: EP

REN Ceased due to non-payment of the annual fee